UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044186
Receipt number R000050439
Scientific Title A Study on the Effect of Food Containing Plant Extract on QOL -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-
Date of disclosure of the study information 2021/05/14
Last modified on 2022/03/01 11:21:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Effect of Food Containing Plant Extract on QOL
-A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-

Acronym

A Study on the Effect of Food Containing Plant Extract on QOL

Scientific Title

A Study on the Effect of Food Containing Plant Extract on QOL
-A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-

Scientific Title:Acronym

A Study on the Effect of Food Containing Plant Extract on QOL

Region

Japan


Condition

Condition

No

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the effect of food containing plant extract on QOL

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

QOL questionnaire

Key secondary outcomes

complexion


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Foods containing plant extract, 4 weeks consumption

Interventions/Control_2

Foods not containing plant extract, 4 weeks consumption

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

1)Healthy Japanese males and females aged 20 to 64 years-old.
2)Subjects who tend to feel tired easily in daily life.
3)Subjects who can make self-judgment and are voluntarily giving written informed consent.

Key exclusion criteria

Subjects (who)
1)are judged by doctors to have a high probability of chronic fatigue syndrome.
2)contract or are under treatment for serious diseases (e.g., liver disease, kidney disease, digestive disease, heart disease, respiratory disease, endocrine disease, and/or other metabolic disease).
3)have a chronic disease and use medications.
4)contract or have a surgical history of digestive disease affecting digestion and absorption.
5)may have allergy to test foods.
6)have alcohol intake more than approximately 20 g/day of pure alcohol equivalent or a habit of drinking not less than 4 days a week.
7)can't stop drinking from 2 days before each measurement.
8) smoke 10 or more cigarettes a day, or cannot quit smoking during from waking to inspection completed.
9)use drugs, supplements, or functional foods associated with fatigue recovery.
10)are shiftworker, midnight worker and/or hard worker.
11)have regular hard exercise.
12) are pregnant or breast-feeding or planned to become pregnant during the study period.
13) have donated over 200 mL of blood and/or blood components within the last one month prior to the current study or over 400 mL of blood and/or blood components within the last three months prior to the current study.
14)are participating in or willing to participate in other clinical studies.
15)are judged as unsuitable for the current study by the investigator for other reasons.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Kayoko
Middle name
Last name Numano

Organization

Ebisu Ray Clinic, Shinkoukai Medical Corporation

Division name

Dermatology

Zip code

150-0013

Address

1-11-2 Ebisu, Shibuya-ku, Tokyo

TEL

03-6277-3917

Email

kaco@yahoo.co.jp


Public contact

Name of contact person

1st name Yoshika
Middle name
Last name Komori

Organization

KSO Corporation

Division name

Sales department

Zip code

105-0023

Address

1-9-7 Shibaura, Minato-ku, Tokyo

TEL

03-3452-7733

Homepage URL


Email

eigyou27@kso.co.jp


Sponsor or person

Institute

KSO Corporation

Institute

Department

Personal name



Funding Source

Organization

TOYO SHINYAKU Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

General Incorporated Association Clinical Research Review Center

Address

2972-8-603 Ishikawacho, Hachiouji-shi, Tokyo

Tel

090-3547-6398

Email

crrctakashima@kpd.biglobe.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 14 Day


Related information

URL releasing protocol

https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000050439

Publication of results

Published


Result

URL related to results and publications

http://www.pieronline.jp/content/article/0386-3603/49120/2127

Number of participants that the trial has enrolled

50

Results

Statistically significant difference was confirmed in the primary outcome.

Results date posted

2022 Year 03 Month 01 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Males and females aged 20 to 64years old.

Participant flow

Enrolled(n=50)
Completed(n=50)
Analysed(n=35)

Adverse events

No adverse events were observed that be related to test food.

Outcome measures

QOL questionnaire

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2021 Year 04 Month 12 Day

Date of IRB

2021 Year 04 Month 21 Day

Anticipated trial start date

2021 Year 05 Month 15 Day

Last follow-up date

2021 Year 07 Month 04 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 05 Month 12 Day

Last modified on

2022 Year 03 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050439


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name